Gallbladder Carcinoma — Trials

Gallbladder Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 18
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 11%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 51–56 of 56 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01425879	MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery	completed	Phase 2	8	National Cancer Institute (NCI)NIH	1	Jun 17, 2016	clinicaltrials
NCT01267344	A Randomized Study of GEMOX With or Without Cetuximab in Locally Advanced and Metastatic BTC(BTC)	completed	Phase 2	122	National Health Research Institutes, TaiwanOTHER	1	May 4, 2016